158 related articles for article (PubMed ID: 38784027)
1. Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.
Khanna J; Kumar S; Mehta S; Chaudhary J; Jain A
J Pharm Technol; 2024 Jun; 40(3):142-151. PubMed ID: 38784027
[No Abstract] [Full Text] [Related]
2. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
Shouqair TM; Rabbani SA; Sridhar SB; Kurian MT
Cureus; 2022 Apr; 14(4):e24019. PubMed ID: 35573572
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevancy and determinants of potential drug-drug interactions in chronic kidney disease patients: results from a retrospective analysis.
Saleem A; Masood I; Khan TM
Integr Pharm Res Pract; 2017; 6():71-77. PubMed ID: 29354553
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Potential Drug-Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital.
Santos-Díaz G; Pérez-Pico AM; Suárez-Santisteban MÁ; García-Bernalt V; Mayordomo R; Dorado P
Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32751436
[TBL] [Abstract][Full Text] [Related]
5. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of potential drug-drug interactions in a public and private hospital among chronic kidney disease patients in Khyber Pakhtunkhwa: A retrospective cross-sectional study.
Zafar R; Rehman IU; Shah Y; Ming LC; Goh HP; Goh KW
PLoS One; 2023; 18(9):e0291417. PubMed ID: 37773947
[TBL] [Abstract][Full Text] [Related]
7. Potential drug-drug interactions in outpatients with depression of a psychiatry department.
Chen Y; Ding L
Saudi Pharm J; 2023 Feb; 31(2):207-213. PubMed ID: 36942274
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Potential Drug-Drug Interactions in Outpatients with Dyslipidemia.
Lalatović N; Pantović S; Nedović-Vuković M; Kostić M
Iran J Public Health; 2023 Jul; 52(7):1466-1475. PubMed ID: 37593497
[TBL] [Abstract][Full Text] [Related]
9. Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety.
Noor S; Ismail M; Khan F
Front Pharmacol; 2019; 10():1032. PubMed ID: 31607905
[No Abstract] [Full Text] [Related]
10. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
[TBL] [Abstract][Full Text] [Related]
12. Assessment of drug interactions and their associated factors among patients with cardiovascular diseases: a cross-sectional study from the occupied Palestinian territory.
Al-Jabi SW; Aldabe L; Alhaj-Asaad L; Thaher M; Zyoud SH; Sweileh WM
Lancet; 2021 Jul; 398 Suppl 1():S8. PubMed ID: 34227990
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients.
Tecen-Yucel K; Bayraktar-Ekincioglu A; Yildirim T; Yilmaz SR; Demirkan K; Erdem Y
J Manag Care Spec Pharm; 2020 Oct; 26(10):1291-1296. PubMed ID: 32996393
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of potential drug-drug interactions in older adults with psychiatric disorders: a retrospective study.
Liu Y; Yang M; Ding Y; Wang H; Zhang H; Wang D; Zhuang T; Ji M; Cui Y; Wang H
BMC Psychiatry; 2022 Aug; 22(1):563. PubMed ID: 35996119
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of potential drug-drug interactions in intensive care unit.
Dagdelen MS; Gulen D; Ceylan I; Girgin NK
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5801-5806. PubMed ID: 34604971
[TBL] [Abstract][Full Text] [Related]
16. Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology.
Pirnejad H; Amiri P; Niazkhani Z; Shiva A; Makhdoomi K; Abkhiz S; van der Sijs H; Bal R
Int J Med Inform; 2019 Jul; 127():18-26. PubMed ID: 31128828
[TBL] [Abstract][Full Text] [Related]
17. Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
Noor S; Ismail M; Ali Z
BMC Pharmacol Toxicol; 2019 Jul; 20(1):45. PubMed ID: 31349877
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan.
Nusair MB; Al-Azzam SI; Arabyat RM; Amawi HA; Alzoubi KH; Rabah AA
Saudi Pharm J; 2020 Feb; 28(2):155-160. PubMed ID: 32042253
[TBL] [Abstract][Full Text] [Related]
19. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
20. An Assessment of Different Decision Support Software from the Perspective of Potential Drug-Drug Interactions in Patients with Chronic Kidney Diseases.
Bektay MY; Buker Cakir A; Gursu M; Kazancioglu R; Izzettin FV
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
